RadNet/$RDNT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About RadNet
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
Ticker
$RDNT
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
8,773
ISIN
US7504911022
Website
RadNet Metrics
BasicAdvanced
$4.2B
-
-$0.43
1.47
-
Price and volume
Market cap
$4.2B
Beta
1.47
52-week high
$84.56
52-week low
$45.00
Average daily volume
605K
Financial strength
Current ratio
2.01
Quick ratio
1.884
Long term debt to equity
146.367
Total debt to equity
153.632
Interest coverage (TTM)
0.90%
Profitability
EBITDA (TTM)
224.191
Gross margin (TTM)
18.61%
Net profit margin (TTM)
-1.73%
Operating margin (TTM)
4.45%
Effective tax rate (TTM)
54.91%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
1.65%
Return on equity (TTM)
0.33%
Valuation
Price to revenue (TTM)
2.258
Price to book
4.72
Price to tangible book (TTM)
42.03
Price to free cash flow (TTM)
53.964
Free cash flow yield (TTM)
1.85%
Free cash flow per share (TTM)
104.87%
Growth
Revenue change (TTM)
12.76%
Earnings per share change (TTM)
-237.08%
3-year revenue growth (CAGR)
11.62%
10-year revenue growth (CAGR)
9.86%
3-year earnings per share growth (CAGR)
9.76%
10-year earnings per share growth (CAGR)
7.61%
What the Analysts think about RadNet
Analyst ratings (Buy, Hold, Sell) for RadNet stock.
Bulls say / Bears say
RadNet's acquisition of iCAD, Inc. for approximately $103 million is expected to enhance its AI-powered breast cancer detection capabilities, potentially increasing market share and revenue. (stocktitan.net)
The expansion of RadNet's Enhanced Breast Cancer Detection (EBCD) program to include major Southern California physician groups broadens its service reach to nearly 600,000 individuals, indicating strong growth potential. (financialcontent.com)
RadNet's subsidiary, DeepHealth, has launched new AI-powered solutions like DeepHealth OS and SmartTechnology™, positioning the company at the forefront of medical imaging innovation. (stocktitan.net)
RadNet's Q4 2024 earnings missed analyst expectations by $0.13, raising concerns about its financial performance. (investing.com)
The company's stock experienced a significant drop of 8.71% following the announcement of a public offering priced at $29.75 per share, suggesting potential dilution concerns among investors. (businessinsider.com)
RadNet's stock entered oversold territory with an RSI reading of 27.1, indicating potential bearish momentum in the market. (nasdaq.com)
Data summarised monthly by Lightyear AI. Last updated on 11 Jul 2025.
RadNet Financial Performance
Revenues and expenses
RadNet Earnings Performance
Company profitability
RadNet News
AllArticlesVideos
Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet's AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California
GlobeNewsWire·6 days ago
RadNet Secures $100 Million Incremental Term Loan to Fund Acquisitions and Corporate Initiatives
GlobeNewsWire·1 month ago
RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for RadNet stock?
RadNet (RDNT) has a market cap of $4.2B as of July 15, 2025.
What is the P/E ratio for RadNet stock?
The price to earnings (P/E) ratio for RadNet (RDNT) stock is 0 as of July 15, 2025.
Does RadNet stock pay dividends?
No, RadNet (RDNT) stock does not pay dividends to its shareholders as of July 15, 2025.
When is the next RadNet dividend payment date?
RadNet (RDNT) stock does not pay dividends to its shareholders.
What is the beta indicator for RadNet?
RadNet (RDNT) has a beta rating of 1.47. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.